Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Biocon Biologics Gets Health Canada Nod for Yesintek, a Biosimilar to Stelara

Biocon Biologics commercial partner launches psoriatic arthritis injection in Japan

Written By Ruchika Sharma21 May 2025 12:29 PM IST

Ustekinumab, a monoclonal antibody, is approved for the treatment of psoriasis vulgaris and psoriatic arthritis.

Bharat Biotech Oral Cholera vaccine Hillchol shows success in Phase III clinical studies

Bharat Biotech Oral Cholera vaccine Hillcholl shows success in Phase III studies

Written By Ruchika Sharma21 May 2025 11:30 AM IST

Hyderabad: Bharat Biotech's Oral Cholera Vaccine Hillchol has demonstrated against both Ogawa and Inaba serotypes, proving non-inferior in...

Lupin Launches Bioequivalent of Xigduo XR in US Across Multiple Strengths

Lupin collaborate with Honeywell for usage of propellant for inhalers

Written By Ruchika Sharma20 May 2025 3:45 PM IST

Mumbai: Global pharma major Lupin Limited has announced its plan to use Honeywell's Solstice Air (HFO-1234ze cGMP) propellant to transform respiratory...

Janssen-Cilag Guselkumab receives UK nod for Crohn's disease, ulcerative colitis

Written By Ruchika Sharma20 May 2025 2:45 PM IST

Janssen-Cilag Limited has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for guselkumab (Tremfya) to treat...

NPPA Finally Allows GSK to Discontinue Grisovin FP

GSK Blenrep combos win approval in Japan for multiple myeloma

Written By Ruchika Sharma20 May 2025 1:45 PM IST

GSK plc has received approval for Blenrep combinations from Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of adults with...

AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosus

AstraZeneca successfully completes acquisition of EsoBiotec

Written By Ruchika Sharma20 May 2025 12:27 PM IST

AstraZeneca has successfully completed the acquisition of EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated...

Shilpa Biologicals, Stein Cares Ink Exclusive Biosimilar Licensing Pact for Latin America

Pfizer strikes cancer drug deal with China's 3SBio

Written By Ruchika Sharma20 May 2025 11:30 AM IST

3SBio plans to initiate the first Phase 3 study in China in 2025.

Aarti Pharmalabs Gets Single Observation in USFDA Inspection at Tarapur Unit

USFDA clears first blood test used in diagnosing Alzheimer's Disease

Written By Ruchika Sharma19 May 2025 5:03 PM IST

The U.S. Food and Drug Administration (USFDA) has cleared for marketing the first in vitro diagnostic device that tests blood to aid in diagnosing...

Marksans Pharma Gets USFDA Nod for Generic Tessalon Capsules

Marksans Pharma arm Relonchem gets marketing authorization for Sennosides Tablets in UK

Written By Ruchika Sharma19 May 2025 4:00 PM IST

Mumbai: Marksans Pharma Limited has announced that its wholly owned subsidiary Relonchem Limited has received Marketing Authorization for the...

Cipla Gets 2 USFDA Observations for Goa Facility

Cipla arm Mahape facility gets VAI status from USFDA

Written By Ruchika Sharma19 May 2025 11:00 AM IST

Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has classified the current Good Manufacturing Practices...

Roche Itovebi gets European Commission nod

Roche receives USFDA approval for VENTANA MET (SP44) RxDx Assay as companion diagnostic in non-small cell lung cancer

Written By Ruchika Sharma18 May 2025 2:30 PM IST

Basel: Roche has announced that the FDA has approved the VENTANA MET (SP44) RxDx Assay, the first companion diagnostic approved to aid in determining...

Bristol Myers Squibb Wins USFDA Approval for Opdivo Combo in Hodgkin Lymphoma

Bristol Myers Squibb bags European Commission approval for Opdivo combo in lung cancer treatment

Written By Ruchika Sharma18 May 2025 11:45 AM IST

Princeton: Bristol Myers Squibb has announced that the European Commission (EC) has approved the perioperative regimen of neoadjuvant...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok